PM Pediatric Care’s Post

Great news from Moderna: #FDA has approved the #mRNA based #RSV vaccine mRESIVA. Especially for #children and people over 65, RSV (Respiratory Syncytial Virus) can cause serious complications. According to the CDC (Centers for Disease Control and Prevention) each year in the United States, RSV leads to approximately: - 2.1 million outpatient (non-hospitalization) visits among children younger than 5 years old. - 58,000-80,000 hospitalizations among children younger than 5 years old. - 60,000-160,000 hospitalizations among adults 65 years and older. - 6,000-10,000 deaths among adults 65 years and older - 100–300 deaths in children younger than 5 years old.   So, another important step in science to avoid severe medical complications. #mRNA, #vaccines, #science Foto: Moderna

Get vaccinated against pneumonia…before it leaves you breathless! Pneumonia, a lung infection often triggered by a bacterial or viral infection, causes the air sacs of one or both lungs to fill up with fluid and pus. This can make breathing difficult and can swiftly turn into a life-threatening condition especially for the elderly and those suffering from chronic medical conditions such as diabetes, heart, lung, kidney or liver disease.. Getting vaccinated is the best way to protect yourself and your loved ones from this disease – and now, we are offering Pneumococcal Vaccine (Prevenar 13) for the promotional price of only RM233 (NP: RM283) per dose. Kindly note that the price is valid for self-pay outpatients aged 18 and above only, and it does not include doctor’s consultation fees or other hospital charges. Available for a limited time only, while stock lasts at our Health Screening Centre (HSC) and Outpatient Department (Geriatrics, Respiratory Medicine, Infectious Diseases, Nephrology or Rheumatology specialists). To make an appointment: 📞 03 5639 1389 (Health Screening Centre) / 03 5639 1212 (Outpatient Department)  📧 sjmc.hsc@rsdhealth.com #sjmc #subangjayamedicalcentre #respiratory #respiratoryhealth #respiratorycare #lungs #lunghealth #lungdisease #pneumonia #pneumococcal  #pneumococcalvaccination  #pneumoniaawareness #vaccine #getvaccinated

Researchers in Ohio studied 152 severely ill adult patients who were admitted to Ohio State University Hospital with Acute Respiratory Failure (ARF) between May 2020 and November 2022. Of these patients, 112 tested positive for COVID-19, while 40 did not. Among the 112 COVID-positive ARF patients, 20 had received COVID-19 “vaccines” and 89 had not. The death rate during hospitalization was 37% in the unvaccinated group, while it was 70% in the vaccinated group. The vaccine almost doubled the risk of dying from COVID-19 respiratory disease. The death rate was lower among all age groups if they were not vaccinated. The vaccinated group had higher rates of comorbidities (other health problems); however, even when the data was adjusted for this using the Charlson Comorbidity Score, the results still showed that being COVID-19 vaccinated carried a higher risk of death from COVID-19 respiratory disease. The researchers also compared antibody levels among the patients. The vaccinated group had higher levels of IgG4 antibodies, which are known to promote immune tolerance or antibody-dependent enhancement of the disease.

**Nirmatrelvir-Ritonavir No Aid for Long COVID Symptoms** 💊🔬😷 A recent study revealed that nirmatrelvir-ritonavir, administered for a 15-day course, does not alleviate long COVID symptoms at the 10-week mark in a vaccinated cohort. Despite its effectiveness in reducing hospitalization and severity of acute COVID-19, this antiviral treatment showed no significant benefit in addressing the prolonged symptoms experienced by long COVID patients. These findings underscore the need for continued research into effective treatments for long COVID. #LongCOVID #AntiviralTreatment #MedicalResearch 💊🔬😷

RSV vaccine makers vying for market share in second year of shots The U.S. Centers for Disease Control and Prevention said last month the shots should be used in adults 75 and older, as well as those who are 60 to 74 and have an increased risk of severe RSV due to medical conditions. Last year - the first year the shots were on the market - the age had effectively been 60 and up. #respiratorysyncytialvirus I #mResvia I #marketshare I CENTERS FOR DISEASE CONTROL AND PREVENTION, US PUBLIC HEALTH SERVICE I Moderna I Pfizer I GSK I FDA Read more: https://lnkd.in/grKdBTMn

To date there are 10 confirmed measles cases in Florida….measles is a really, really scary disease. For those who are ill up to 3/100 will end up in a Pediatric ICU with either encephalitis or pneumonitis; and it has a per case fatality rate of from 1-3 per 1,000 cases. We have NO treatment for this virus and all that we can offer is supportive care….that’s it. There are 2 basic things that we can do, and the “surgeon general” of Florida is NOT advising that we do either of these things: 1) Is isolation. Measles has one of the highest R naughts, it’s the measure of infectivity, we know of…>12. That means every infected person will infect AT LEAST 12 others if not more. That is why we REQUIRE all suspected and confirmed cases isolate. Period. 2) The 2nd is to get vaccines to those who have not been vaccinated. That to date Florida’s Surgeon General has done neither of these two things is grossly negligent. To put this into context: if I did something similar in the ER, my license would be revoked. This is beyond incompetence and the current administration in Florida has proven that it doesn’t care about the lives of it’s citizens.

Data captured from a risk-benefit analysis supports the use of primary series #mRNACOVID19vaccines for young #children and #infants, regardless of underlying medical conditions or infection-induced immunity. #COVID19 #COVID19vaccine 💉 https://brnw.ch/21wHugM

World Hepatitis Day: A Call to Action by Dr. Dibya Singha 💪🩺 As an orthopedic surgeon, I may not treat hepatitis directly, but I understand the importance of overall health. Hepatitis, a silent threat affecting millions globally, deserves our attention. 🌎 On World Hepatitis Day, let's raise awareness about this often-overlooked disease. Hepatitis can cause liver damage, but early detection and treatment can make a world of difference. 🔬 Remember: Regular check-ups are crucial. 💉 Vaccinations can protect you and your loved ones. 🛡️ Open conversations about hepatitis can reduce stigma.🗣️ Let's work together to eliminate hepatitis and build a healthier future. 🤝 #WorldHepatitisDay #HepatitisAwareness #HepatitisPrevention #HepFreeFuture #LiverHealth #HealthyLifestyle #EarlyDetection #GetVaccinated #EndHepatitis #PublicHealth

A silent Threat: How medical Health Workers can easily get hepatitis B due to vaccination negligence Hepatitis B, a serious liver infection, poses a significant threat to healthcare workers worldwide. While a safe and effective vaccine exists, a concerning number of medical professionals remain unvaccinated putting themselves and their patients at risk. I think this negligence demands immediate attention and action Why are Healthcare workers vulnerable ? Healthcare workers face a heightened risk of exposure to hepatitis B due to: 📌 Exposure to infected blood and bodily fluids: Healthcare workers are regularly exposed to needlestick injuries, blood splashes and other bodily fluids which can transmit the virus. Many patients are unaware of their hepatitis B status, increasing the risk of transmission . #Addressing the problem 📌 Implementing mandatory vaccination policies for all healthcare workers would significantly reduce the risk of transmission 📌 Educating healthcare workers and creating awareness campaigns about the risks of hepatitis B and benefits of vaccination is essential 📌 Ensuring easy and affordable access to vaccine for all healthcare workers is important . Vaccination is the most effective way to prevent hepatitis B infection. It's time to eliminate the negligence surrounding hepatitis B vaccination among healthcare workers and ensure the safety of both healthcare professionals and their patients. What do you think? _________________ Are you meeting me for the first time? I am @NFORMI BLESSING, a medical laboratory scientist. I analyze tests, identify patterns, and provide accurate diagnoses to help healthcare professionals make informed treatment decisions. Please kindly #connect with me and let us grow together. #healthcare #hepatitisB #linkedinacceleratorwithlynn #connection #medicallaboratory #scientist #vaccines

PSV20 HEs FOR OLDER ADULTS' PNEUMOCOCCAL PREVENTION. The objective of this study was to assess the clinical and economic impact of replacing existing vaccination strategies with the PCV20, which has the potential to reduce disease burden and associated costs. What was learned from the study? PCV20 was estimated to reduce invasive pneumococcal disease (IPD) cases by 3838, non-bacteremic pneumonia (NBP) cases by 10,380, and deaths by 1865 compared to PCV13→PPSV23; corresponding reductions for PCV20 vs. PCV15→ PPSV23 were 2775, 7803, and 1348. The use of PCV20 is projected to be cost saving among Argentinean adults, lowering total costs by $87.6 million and $80.8 million compared to PCV13→PPSV23 and PCV15→PPSV23, respectively. This economic evaluation of PCV20 will help inform decision-makers in Argentina and in other Latin American countries who will soon consider the use of novel pneumococcal conjugate vaccines